With expertise in both science and business, Kristin Tweel bridges the two worlds to deliver impactful, real-world solutions.

As Director of Sector Innovation at Genome Atlantic, she leads collaborations with industry, researchers, and government to develop genomics-enabled projects that tackle pressing challenges and fuel economic growth. With a PhD in Pharmacology and an MBA, Kristin pairs deep scientific expertise with strong business acumen. Her career spans cancer research, biotechnology, and strategic business development.

At Genome Atlantic, where she has worked for more than a decade, Kristin has helped shape the organization’s innovation portfolio. She is known for translating complex science into compelling business opportunities, forging partnerships, and securing investments. Her leadership has delivered impactful projects that benefit industries and communities across Atlantic Canada and beyond.